Biomed Pharmaceuticals Announces Key Additions to Management Team
Craig Mears and Leo Gianacopoulos Join Biomed
SHARON HILL, Pa. -- September 20, 2013
Biomed Pharmaceuticals, (“Biomed” or the “Company”), a leading national
specialty infusion pharmacy provider, has named Craig Mears as Senior Vice
President of Sales and Marketing, effective immediately. Mr. Mears has over 26
years of experience in sales leadership, patient advocacy, product
development, marketing, operations, and clinical program development. Most
recently, Mr. Mears was with Biogen Idec where he was responsible for building
the hemophilia field force and business strategy, hiring the field management
team and managing community relationships.Prior to that, Mr. Mears was with
Accredo, the specialty pharmacy division of Express Scripts from 1996-2012.
Mr. Mears has a Bachelor of Business Administration from Baldwin Wallace
College in Berea, Ohio.
Leo Gianacopoulos has been named Senior Vice President of Pharmacy Operations,
effective immediately. Mr. Gianacopoulos has 23 years of experience in
specialty pharmacy management. Most recently, Mr. Gianacopoulos was Vice
President of Operations at BioScrip where he was responsible for infusion
operations (east) and established operations for a national hemophilia program
with centralized intake and pharmacy fulfillment services. Prior to that, Mr.
Gianacopoulos was Vice President of Operations for Biological Therapies for
Coram Healthcare from 2003-2009. Mr. Gianacopoulos has a Bachelor of Science
in Pharmacy from the University of the Sciences / Philadelphia College of
Pharmacy & Science. He also is a Certified Project Management Professional
through PMI, Inc. and has a Master Certificate in Applied Project Management
from Villanova University. Mark Strollo will transition his operational
oversight to Mr. Gianacopoulos and will assume the role of Senior Vice
President of Clinical and Regulatory Matters to further strengthen the service
to our patients and other partners.
“We welcome Craig and Leo to the executive management team. We have positioned
our company to execute on our growth strategy and to deliver superior
healthcare programs and services to our patients, referral sources, advocacy
groups, payers and pharmaceutical manufacturer partners,” commented Gaston
Bernstein, Chief Executive Officer of Biomed.
About Biomed Pharmaceuticals
The Company is a leading pharmacy provider of intravenous and injectable
medications for patients with chronic disorders. Biomed provides Intravenous
Immunoglobulin (“IVIG”) therapy for immune, neurological and transplant
patients, as well as Factor products for Hemophilia patients and DMARDs and
TNF Inhibitors for Rheumatoid Arthritis patients. In addition to dispensing
the appropriate medications nationally, Biomed’s nurses educate patients and
caregivers, infuse medications and provide support and follow up throughout
therapy. Through its ACHC-accredited and strategically located pharmacies,
Biomed serves a national patient base in the United States. For more
information, visit www.biomed-rx.com.
Lisa Stotts, 610-586-2311
Senior Vice President & CFO
Press spacebar to pause and continue. Press esc to stop.